Carl Deirmengian, MD
Carl Deirmengian, MD, is a practicing joint replacement surgeon at the Rothman Institute in Philadelphia, PA. He completed his BA in chemistry at Princeton University in 1992, his MD at Harvard Medical School in 1996, his residency in orthopaedic surgery at the University of Pennsylvania in 2005, and his Fellowship in Adult Reconstructive Surgery of the Hip and Knee at Rush University Medical Center in Chicago in 2006. His numerous awards and achievements include: The Mark Coventry Award for outstanding science research-given by the Knee Society for his research in using biomarkers to identify infection in the human joint, The DeForest Willard award for outstanding chief resident at the University of Pennsylvania, the Orthopaedic Research and Education Fund award for outstanding research and the Leonard Marmor Award for joint arthroplasty. In 2009, Dr. Deirmengian was selected as a “John Insall Traveling Fellow” and completed a month long fellowship with the top total knee surgeons throughout the United States. He has numerous publications for various research projects throughout his career. Dr. Deirmengian is Founder of CD Diagnostics, a BioStar portfolio company acquired by Zimmer Biomet.